CircSAMD4A accelerates cell proliferation of osteosarcoma by sponging miR-1244 and regulating MDM2 mRNA expression

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Osteosarcoma (OS) is a primary bone malignancy with limited treatment options.
• Circular RNAs (circRNAs) are emerging as key regulators in various cancers, including OS.
• Understanding novel molecular mechanisms is crucial for developing effective OS therapies.

Purpose of the Study:

• To identify novel differentially expressed circRNAs in osteosarcoma.
• To investigate the functional role and mechanism of circSAMD4A in OS progression.
• To explore the circSAMD4A/miR-1244/MDM2 regulatory axis as a potential therapeutic target.

Main Methods:

• Analysis of circRNA expression profiles in OS cell lines and tissues.
• In vitro and in vivo assays to assess the effect of circSAMD4A on OS proliferation and stemness.
• Mechanism studies involving RNA immunoprecipitation and luciferase reporter assays to elucidate the circSAMD4A/miR-1244/MDM2 interaction.

Main Results:

• A novel circRNA, named circSAMD4A, was identified and found to be highly expressed in OS tissues.
• circSAMD4A significantly promoted OS cell proliferation and invasion in vitro and in vivo.
• circSAMD4A enhances osteosarcoma stemness by sponging miR-1244, which targets MDM2.

Conclusions:

• The circSAMD4A/miR-1244/MDM2 regulatory loop plays a critical role in osteosarcoma development.
• circSAMD4A represents a potential diagnostic biomarker and therapeutic target for osteosarcoma.
• Targeting this circRNA-miRNA-mRNA axis may offer a novel strategy for OS treatment.